ScholarIQanswers from OpenAlex

Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes

PaperCitations, authors & open-access status

Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes have?

ScholarIQcitation count

Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes has 271 citations in the OpenAlex counts ScholarIQ stores.

When was Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes published?

ScholarIQyear

Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes has 2017 year in the ScholarIQ index.

What is the open-access status of Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes?

ScholarIQoa status

Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes has bronze oa status in the ScholarIQ index.

What is the DOI of Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes?

ScholarIQdoi

The DOI for Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes is on the source record.

What is the PMID of Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes?

ScholarIQpmid

The PMID for Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes is on the source record.

What is the OpenAlex record for Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes?

ScholarIQopenalex

The OpenAlex for Left Ventricular Assist Device Therapy in Advanced Heart Failure: Patient Selection and Outcomes is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial